January/February 2025 • PharmaTimes Magazine • 4-5


Contents


Features

Pharma/NHS shifts are imminent throughout the coming year


Transforming healthcare with automated mass spectrometry


Embracing the AI revolution across pharma communications


Promise of N-of-1 studies for rare disease clinical development


Why early cancer detection for everyone may not be desirable


Analysis

Imperative for AI-powered productivity enhancement


How the emc supports pharma in improving access to medicine

How effective digital design can streamline regulatory approval


Unravelling the various mysteries of neurological conditions


Safeguarding concerns as the era of Wegovy looms large


SmartPeople

16.
Research resolutions
Do one thing differently in '25 to address the diversity challenge


21.
Withering heights
Industry comms guru Hayley Woods begins her intrepid column


34.
New view for future crew
Easing the burden of myeloma on patients and the NHS


36.
Your moves
Where, why and how


38. 
Clins and outs
Why ClinOps has been suddenly thrust into the spotlight


0